Inhibition of muscle fibrosis results in increases in both utrophin levels and the number of revertant myofibers in Duchenne muscular dystrophy.
about
Evaluation of muscular changes by ultrasound Nakagami imaging in Duchenne muscular dystrophy.Pharmacological therapeutics targeting the secondary defects and downstream pathology of Duchenne muscular dystrophyEliminating Nox2 reactive oxygen species production protects dystrophic skeletal muscle from pathological calcium influx assessed in vivo by manganese-enhanced magnetic resonance imaging.NADPH oxidase mediates microtubule alterations and diaphragm dysfunction in dystrophic mice.Sulforaphane mitigates muscle fibrosis in mdx mice via Nrf2-mediated inhibition of TGF-β/Smad signaling.Cross-section and feasibility study on the non-invasive evaluation of muscle hemodynamic responses in Duchenne muscular dystrophy by using a near-infrared diffuse optical technique
P2860
Inhibition of muscle fibrosis results in increases in both utrophin levels and the number of revertant myofibers in Duchenne muscular dystrophy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Inhibition of muscle fibrosis ...... n Duchenne muscular dystrophy.
@ast
Inhibition of muscle fibrosis ...... n Duchenne muscular dystrophy.
@en
type
label
Inhibition of muscle fibrosis ...... n Duchenne muscular dystrophy.
@ast
Inhibition of muscle fibrosis ...... n Duchenne muscular dystrophy.
@en
prefLabel
Inhibition of muscle fibrosis ...... n Duchenne muscular dystrophy.
@ast
Inhibition of muscle fibrosis ...... n Duchenne muscular dystrophy.
@en
P2093
P2860
P356
P1433
P1476
Inhibition of muscle fibrosis ...... in Duchenne muscular dystrophy
@en
P2093
Mark Pines
Olga Genin
Orna Halevy
Oshrat Levi
P2860
P304
23249-23260
P356
10.18632/ONCOTARGET.4021
P407
P577
2015-09-01T00:00:00Z